Lori Anne Kunkel, Director at Loxo Oncology, Inc. (LOXO), sold 78,460 shares at $180.28 ($14.1M) on 2018-06-14, disclosed to the SEC on 2018-06-18.
Open-market sale of $14.1M LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $180.28 | 28,440 | $5.1M | 36.3% |
| 2 | $180.28 | 28,440 | $5.1M | 36.3% |
| 3 | $181.48 | 2,411 | $438K | 3.1% |
| 4 | $181.48 | 2,411 | $438K | 3.1% |
| 5 | $182.35 | 1,541 | $281K | 2.0% |
| 6 | $182.35 | 1,541 |
| $281K |
| 2.0% |
| 7 | $175.64 | 1,235 | $217K | 1.5% |
| 8 | $175.64 | 1,235 | $217K | 1.5% |
| 9 | $177.12 | 5,601 | $992K | 7.0% |
| 10 | $177.12 | 5,601 | $992K | 7.0% |
| 11 | $177.79 | 4 | $711 | 0.0% |
| Total | $179.84 avg | 78,460 | $14.1M | 100% |
| Filing → |
| CRIS | SELL | 2019-01-25 | $16K | — | Filing → |
| LOXO | SELL | 2018-10-03 | $852K | — | Filing → |
| LOXO | SELL | 2018-04-24 | $782K | — | Filing → |